These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31921194)

  • 1. Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus.
    Gil L; Martín A; Lazo L
    Front Immunol; 2019; 10():2946. PubMed ID: 31921194
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects for a dengue virus vaccine.
    Whitehead SS; Blaney JE; Durbin AP; Murphy BR
    Nat Rev Microbiol; 2007 Jul; 5(7):518-28. PubMed ID: 17558424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interplay of Dengue Virus Morphological Diversity and Human Antibodies.
    Lok SM
    Trends Microbiol; 2016 Apr; 24(4):284-293. PubMed ID: 26747581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue vaccine: reliably determining previous exposure.
    Ariën KK; Wilder-Smith A
    Lancet Glob Health; 2018 Aug; 6(8):e830-e831. PubMed ID: 29941282
    [No Abstract]   [Full Text] [Related]  

  • 5. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Call to action for dengue vaccine failure.
    Mahalingam S; Herring BL; Halstead SB
    Emerg Infect Dis; 2013 Aug; 19(8):1335-7. PubMed ID: 23876389
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination models and optimal control strategies to dengue.
    Rodrigues HS; Monteiro MT; Torres DF
    Math Biosci; 2014 Jan; 247():1-12. PubMed ID: 24513243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Dengvaxia a useful vaccine for dengue endemic areas?
    Gubler DJ; Halstead SB
    BMJ; 2019 Oct; 367():l5710. PubMed ID: 31582375
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response to dengue virus and prospects for a vaccine.
    Murphy BR; Whitehead SS
    Annu Rev Immunol; 2011; 29():587-619. PubMed ID: 21219187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique challenges faced by the clinical evaluation of dengue vaccines.
    Edelman R
    Expert Rev Vaccines; 2011 Feb; 10(2):133-6. PubMed ID: 21332260
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of interferences between dengue vaccine serotypes in a monkey model.
    Guy B; Barban V; Mantel N; Aguirre M; Gulia S; Pontvianne J; Jourdier TM; Ramirez L; Gregoire V; Charnay C; Burdin N; Dumas R; Lang J
    Am J Trop Med Hyg; 2009 Feb; 80(2):302-11. PubMed ID: 19190230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune correlates for dengue vaccine development.
    Srikiatkhachorn A; Yoon IK
    Expert Rev Vaccines; 2016; 15(4):455-65. PubMed ID: 26560015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in dengue vaccine development.
    Raviprakash K; Defang G; Burgess T; Porter K
    Hum Vaccin; 2009 Aug; 5(8):520-8. PubMed ID: 19535912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-dengue Vaccines: From Development to Clinical Trials.
    Pinheiro-Michelsen JR; Souza RDSO; Santana IVR; da Silva PS; Mendez EC; Luiz WB; Amorim JH
    Front Immunol; 2020; 11():1252. PubMed ID: 32655561
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines.
    Borges MB; Marchevsky RS; Carvalho Pereira R; da Silva Mendes Y; Almeida Mendes LG; Diniz-Mendes L; Cruz MA; Tahmaoui O; Baudart S; Freire M; Homma A; Schneider-Ohrum K; Vaughn DW; Vanloubbeeck Y; Lorin C; Malice MP; Caride E; Warter L
    PLoS Pathog; 2019 Apr; 15(4):e1007721. PubMed ID: 31009499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.
    Liang H; Lee M; Jin X
    Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4.
    Barban V; Mantel N; De Montfort A; Pagnon A; Pradezynski F; Lang J; Boudet F
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue vaccine: an update on recombinant subunit strategies.
    Martin J; Hermida L
    Acta Virol; 2016 Mar; 60(1):3-14. PubMed ID: 26982462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mosquito control might not bolster imperfect dengue vaccines.
    Paul R; Sousa C; Sakuntabhai A; Devine G
    Lancet; 2014 Nov; 384(9956):1747-8. PubMed ID: 25455246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.